Published date: 13 April 2023
This notice was replaced on 14 July 2023
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Opportunity (published 14 July 2023, last edited 17 July 2023)
Closed early engagement
Contract summary
Industry
Data services - 72300000
Research and development services and related consultancy services - 73000000
Location of contract
London
Procurement reference
tender_361811/1202339
Published date
13 April 2023
Closing date
26 April 2023
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
The Office for Life Sciences (OLS) wishes to procure a three-year contract to produce a database annually on life science companies operating in the UK for 2023, 2024 and 2025. This dataset has been procured since 2009 due to existing data not adequately reflecting the full scope of the life science sector in it's entirety. This dataset is used to support policy making and used extensively in government, by academia and by life science companies. OLS use this data to:
- develop and evaluate strategies and policies, including implementation of the Life Science Vision,
- identify sector strengths and address weaknesses/barriers to help create the conditions for UK business success in life sciences
- monitor and map changes in the sector
- produce an annual Official Statistics report 'Bioscience and Health technology Sector Statistics' (BaHTSS) which provides commentary on data and trends in collaboration with OLS analysts. Previous Datasets can be found here: www.gov.uk/government/collections/bioscience-and-health-technology-database-annual-reports
It is expected that these returns are used as a 'base-line'. The successful supplier will need to build, develop and improve any data outputs, in line with OLS guidance.
Details of the current methodology used to produce the annual database can be found in Annex 2 of our published report, the latest of which can be found here: https://www.gov.uk/government/statistics/bioscience-and-health-technology-sector-statistics-2021/bioscience-and-health-technology-sector-statistics-2021-background-quality-and-user-guide
We are hosting an online supplier engagement event on the 26th April 2023 14:00-15:00 via MS Teams. To register your interest in attending, please email Claire Beaton (claire.beaton@officeforlifesciences.gov.uk) who will send across the invite.
More information
Additional text
-
The Office for Life Sciences (OLS) is a joint unit of the Department for Business, Energy and Industrial Strategy (BEIS) and the Department of Health and Social Care (DHSC), with the objective of maximising the UK's strengths in science and research to support the development and adoption of 21st century health and life sciences technology, delivering the best health outcomes and increasing wider growth and prosperity.
We work with business, other Government Departments and executive agencies, Innovate UK, the Research Councils, public health bodies and other partners to deliver the Strategy for UK Life Sciences, and to create the conditions that allow businesses in our sectors to exploit the latest advances in science and technology. We influence and use our connections to maintain UK global leadership in health and life sciences. We work effectively with industries across these and closely related sectors, building and managing relationships with strategically important companies in our sector.
Our work supports increased inward investment, growth in exports, and resolution of problems that could lead to disinvestment.
Requirements
Data collection
OLS require granular information on each company operating in the UK life science environment. The scope of companies to be included in the database is outlined as follows:
- The database covers the geographical area of England and the Devolved Administrations of Northern Ireland, Scotland and Wales.
- Only companies that are a legal entity, conducting economic activity and have employees in the UK are included. Companies that are wholly or partially owned by non-UK entities are included.
- Only the economic activity of companies attributable to the life sciences sector (medical technology, biopharmaceutical and digital health) is included, Where companies also carry out economic activity in other UK sectors, an estimate of the proportion of total turnover due to life sciences activity is calculated.
OLS holds an existing baseline dataset for life science sites relating to 2009 and 2022. The latest available data, relating to 2023 onwards, should be collected on UK life sciences companies, their subsidiaries and each of their associated sites; these may be newly formed, newly operating in the life sciences sectors, or newly identified established companies. Data can be collected from a range of sources including from data partners , company websites and third party data sources. In previous years; company, site and segmentation information has been gathered from the data partners as well as independent searches carried out by the current provider. Suppliers are expected to review and expand on the list of data providers and sources to ensure they remain up to date and fit for purpose.
About the buyer
Address
1 Victoria Street
London
SW1H 0ET
England
Share this notice
All content is available under the
